Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion

Irinotecan hydrochloride (CPT-11) is a potent topoisomerase I inhibitor and is established and used widely as an antitumor agent. However, it sometimes causes severe side effects such as myelosuppression and diarrhea. These dose-limiting toxicities prevent the adoption of CPT-11 in aggressive chemot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2003-11, Vol.52 (5), p.349-360
Hauptverfasser: KURITA, Akinobu, KADO, Shoichi, KANEDA, Norimasa, ONOUE, Masaharu, HASHIMOTO, Shusuke, YOKOKURA, Teruo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!